Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for SiBone (SIBN : NSDQ)

• Company Description    SI-BONE Inc. is a medical device company which developed the iFuse Implant System(R) for minimally invasive surgical treatment of the sacroiliac joint dysfunction. SI-BONE Inc. is based in Santa Clara, California. Number of Employees: 352

• Price / Volume Information    Yesterday's Closing Price: $13.89 Daily Weekly Monthly 20 Day Moving Average: 371,649 shares Shares Outstanding: 33.88 (millions) Market Capitalization: $470.64 (millions) Beta: 1.40 52 Week High: $34.38 52 Week Low: $11.92 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -35.96% -30.11% 12 Week -27.32% -23.48% Year To Date -37.46% -27.10%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 471 EL CAMINO REAL SUITE 101 - SANTA CLARA,CA 95050 USA ph: 408-207-0700 fax: - investors@si-bone.com http://si-bone.com

• General Corporate Information    Officers Laura A. Francis - Chief Executive Officer Jeffrey W. Dunn - Executive Chairman Anshul Maheshwari - Chief Financial Officer John G. Freund - Director Jeryl L. Hilleman - Director Peer Information SiBone (ABMD) SiBone (DMDS) SiBone (CPWY.) SiBone (EQUR) SiBone (ECIA) SiBone (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 825704109 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/01/22 Share - Related Items Shares Outstanding: 33.88 Most Recent Split Date: (:1) Beta: 1.40 Market Capitalization: $470.64 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.50 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.84 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 8.87% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/01/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.84 Price/Cash Flow: - Price / Sales: 5.11 EPS Growth vs. Year Ago Period: -40.54% vs. Previous Quarter: -20.93% Sales Growth vs. Year Ago Period: 9.77% vs. Previous Quarter: -11.06% ROE 03/31/22 - -44.52 12/31/21 - -38.10 09/30/21 - -32.49 ROA 03/31/22 - -32.13 12/31/21 - -28.02 09/30/21 - -24.32 Current Ratio 03/31/22 - 10.44 12/31/21 - 10.41 09/30/21 - 12.75 Quick Ratio 03/31/22 - 9.48 12/31/21 - 9.73 09/30/21 - 12.04 Operating Margin 03/31/22 - -67.00 12/31/21 - -62.75 09/30/21 - -58.66 Net Margin 03/31/22 - -67.00 12/31/21 - -62.75 09/30/21 - -58.66 Pre-Tax Margin 03/31/22 - -67.00 12/31/21 - -62.75 09/30/21 - -58.66 Book Value 03/31/22 - 3.61 12/31/21 - 4.01 09/30/21 - 4.32 Inventory Turnover 03/31/22 - 1.01 12/31/21 - 1.12 09/30/21 - 1.19 Debt-to-Equity 03/31/22 - 0.29 12/31/21 - 0.26 09/30/21 - 0.24 Debt-to-Capital 03/31/22 - 22.24 12/31/21 - 20.65 09/30/21 - 19.56

Powered by Zacks Investment Research ©